513 related articles for article (PubMed ID: 25585624)
1. Role of the monocyte chemoattractant protein-1/C-C chemokine receptor 2 signaling pathway in transient receptor potential vanilloid type 1 ablation-induced renal injury in salt-sensitive hypertension.
Wang Y; Zhu M; Xu H; Cui L; Liu W; Wang X; Shen S; Wang DH
Exp Biol Med (Maywood); 2015 Sep; 240(9):1223-34. PubMed ID: 25585624
[TBL] [Abstract][Full Text] [Related]
2. [Role of transient receptor potential vanilloid type 1 and C-C chemokine receptor 2 in renal injury induced by salt-sensitive hype].
Zhu FY; Liu WH; Wang XX; Cui L; Shen S; Zhu MJ; Wang YP
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2014 Oct; 36(5):488-95. PubMed ID: 25360645
[TBL] [Abstract][Full Text] [Related]
3. Aggravated renal inflammatory responses in TRPV1 gene knockout mice subjected to DOCA-salt hypertension.
Wang Y; Wang DH
Am J Physiol Renal Physiol; 2009 Dec; 297(6):F1550-9. PubMed ID: 19794112
[TBL] [Abstract][Full Text] [Related]
4. [Role of chemokine receptor 2 in renal damage induced by deoxycorticosterone acetate-salt hypertension].
Sun M; Cui L; Liu WH; Gao Y; Shen S; Zhu MJ; Wang YP
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Feb; 35(1):29-35. PubMed ID: 23469787
[TBL] [Abstract][Full Text] [Related]
5. Deletion of transient receptor potential vanilloid type 1 receptors exaggerates renal damage in deoxycorticosterone acetate-salt hypertension.
Wang Y; Babánková D; Huang J; Swain GM; Wang DH
Hypertension; 2008 Aug; 52(2):264-70. PubMed ID: 18606907
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of TRPV1 against renal fibrosis via inhibition of TGF-β/Smad signaling in DOCA-salt hypertension.
Wang Y; Wang DH
Mol Med; 2011; 17(11-12):1204-12. PubMed ID: 21792478
[TBL] [Abstract][Full Text] [Related]
7. Triptolide attenuates renal damage by limiting inflammatory responses in DOCA-salt hypertension.
Zhang J; Zhu M; Zhang S; Xie S; Gao Y; Wang Y
Int Immunopharmacol; 2020 Dec; 89(Pt A):107035. PubMed ID: 33045566
[TBL] [Abstract][Full Text] [Related]
8. Reversal of vascular macrophage accumulation and hypertension by a CCR2 antagonist in deoxycorticosterone/salt-treated mice.
Chan CT; Moore JP; Budzyn K; Guida E; Diep H; Vinh A; Jones ES; Widdop RE; Armitage JA; Sakkal S; Ricardo SD; Sobey CG; Drummond GR
Hypertension; 2012 Nov; 60(5):1207-12. PubMed ID: 23033370
[TBL] [Abstract][Full Text] [Related]
9. CCL2 mediates early renal leukocyte infiltration during salt-sensitive hypertension.
Alsheikh AJ; Dasinger JH; Abais-Battad JM; Fehrenbach DJ; Yang C; Cowley AW; Mattson DL
Am J Physiol Renal Physiol; 2020 Apr; 318(4):F982-F993. PubMed ID: 32150444
[TBL] [Abstract][Full Text] [Related]
10. Detrimental role of sphingosine kinase 1 in kidney damage in DOCA-salt hypertensive model: evidence from knockout mice.
Lyu B; Wang W; Ji XY; Ritter JK; Li N
BMC Nephrol; 2020 May; 21(1):173. PubMed ID: 32393187
[TBL] [Abstract][Full Text] [Related]
11. Role of substance P in renal injury during DOCA-salt hypertension.
Wang Y; Wang DH
Endocrinology; 2012 Dec; 153(12):5972-9. PubMed ID: 23024265
[TBL] [Abstract][Full Text] [Related]
12. CS-3150, a Novel Nonsteroidal Mineralocorticoid Receptor Antagonist, Shows Preventive and Therapeutic Effects On Renal Injury in Deoxycorticosterone Acetate/Salt-Induced Hypertensive Rats.
Arai K; Morikawa Y; Ubukata N; Tsuruoka H; Homma T
J Pharmacol Exp Ther; 2016 Sep; 358(3):548-57. PubMed ID: 27384074
[TBL] [Abstract][Full Text] [Related]
13. Soluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertension.
Manhiani M; Quigley JE; Knight SF; Tasoobshirazi S; Moore T; Brands MW; Hammock BD; Imig JD
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F740-8. PubMed ID: 19553349
[TBL] [Abstract][Full Text] [Related]
14. Effects of angiotensin-converting enzyme inhibitor and angiotensin type 1 receptor antagonist in deoxycorticosterone acetate-salt hypertensive mice lacking Ren-2 gene.
Peng H; Carretero OA; Alfie ME; Masura JA; Rhaleb NE
Hypertension; 2001 Mar; 37(3):974-80. PubMed ID: 11244026
[TBL] [Abstract][Full Text] [Related]
15. TRPV1 agonism inhibits endothelial cell inflammation via activation of eNOS/NO pathway.
Wang Y; Cui L; Xu H; Liu S; Zhu F; Yan F; Shen S; Zhu M
Atherosclerosis; 2017 May; 260():13-19. PubMed ID: 28324760
[TBL] [Abstract][Full Text] [Related]
16. TNF-alpha inhibition reduces renal injury in DOCA-salt hypertensive rats.
Elmarakby AA; Quigley JE; Imig JD; Pollock JS; Pollock DM
Am J Physiol Regul Integr Comp Physiol; 2008 Jan; 294(1):R76-83. PubMed ID: 17989143
[TBL] [Abstract][Full Text] [Related]
17. Activation of TRPV4 by dietary apigenin antagonizes renal fibrosis in deoxycorticosterone acetate (DOCA)-salt-induced hypertension.
Wei X; Gao P; Pu Y; Li Q; Yang T; Zhang H; Xiong S; Cui Y; Li L; Ma X; Liu D; Zhu Z
Clin Sci (Lond); 2017 Apr; 131(7):567-581. PubMed ID: 28143892
[TBL] [Abstract][Full Text] [Related]
18. Blockade of CCR2 reduces macrophage influx and development of chronic renal damage in murine renovascular hypertension.
Kashyap S; Warner GM; Hartono SP; Boyilla R; Knudsen BE; Zubair AS; Lien K; Nath KA; Textor SC; Lerman LO; Grande JP
Am J Physiol Renal Physiol; 2016 Mar; 310(5):F372-84. PubMed ID: 26661648
[TBL] [Abstract][Full Text] [Related]
19. Obesity induced renal oxidative stress contributes to renal injury in salt-sensitive hypertension.
Quigley JE; Elmarakby AA; Knight SF; Manhiani MM; Stepp DW; Olearzcyk JJ; Imig JD
Clin Exp Pharmacol Physiol; 2009 Jul; 36(7):724-8. PubMed ID: 19207724
[TBL] [Abstract][Full Text] [Related]
20. L/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats.
Toba H; Yoshida M; Tojo C; Nakano A; Oshima Y; Kojima Y; Noda K; Wang J; Kobara M; Nakata T
Hypertens Res; 2011 Apr; 34(4):521-9. PubMed ID: 21270815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
